Clinical biochemistry is one of the most explored and reliable branches of clinical diagnostics and pathology. It includes qualitative and quantitative assessment of molecules and chemical entities in given patient sample such as glucose, minerals, electrolytes, and uric acid. These measurements are used to diagnose the functioning capabilities of body organs. Conventional clinical chemistry analysis involves use of various substrates and enzymes or catalysts to detect and quantify the presence of analytes in a given sample based on principles of colorimetry involving light absorption and refraction phenomenon of specific substance at specific wavelength. It includes use of wet reagents, large set-ups, and requires large volume of samples. Dry chemistry analysis, on the other hand, is based on the reflectance measurement of specific substance at specific wavelength and its comparative study with the standards.
Dry chemistry analyzers comprise highly sensitive multilayered reagent coated slides instead of wet reagents. It requires only 10 ml to 50 ml of sample. The results of dry chemistry analyzers are comparable to conventional wet chemistry analyzers. However, results differ for certain parameters among dry and conventional chemistry analyzers. Dry chemistry analyzers are compact and easy to operate, as these do not require storage space for reagents, there is no need for pipetting of reagents, these are semi to fully automatic, and require small volume of sample. These factors have contributed to high adoption of dry chemistry analyzers in acute care settings, physician offices, etc. Dry chemistry analyzers such as blood glucose analyzers, blood cholesterol analyzers, and blood electrolyte analyzers have been widely used across the globe. There are large number of dry chemistry analyzer manufacturers in the market. Major concern among the users is high cost of test cartridges or slides compared to conventional chemistry analyzer reagents. Moreover, most of the analyzers work on closed system principle, with compatibility with own reagent slides or cartridges.
The global dry chemistry analyzers market can be segmented based on product, technology, ergonomics, end-user, and region. In terms of product, the dry chemistry analyzers market can be bifurcated into analyzer systems and consumables. Consumables include reagent coated cartridges or slides, which need to be disposed after each test. Based on technology, the global dry chemistry analyzers market can be classified into single parameter and multi-parameter. These devices have high throughput, which has led to increase in adoption across health care facilities. In terms of ergonomics, the dry chemistry analyzers market can be categorized into benchtop and stationary. Based on end-user, the dry chemistry analyzers market can be divided into hospitals, independent diagnostic laboratories, blood banks, and others.
In terms of region, the global dry chemistry analyzers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The U.S. has high adoption of technically advanced diagnostic devices and preference for point-of-care testing devices. These factors have led to high uptake of dry chemistry analyzers in the U.S. This is attributed to North America’s high share of the global dry chemistry analyzers market in 2017. Europe is projected to account for second the largest share of the global dry chemistry analyzers market owing to well-established health care infrastructure and demand for preventive and quality health care. Large population, high unmet needs, and increase in health care expenditure are anticipated to contribute to the growth of the dry chemistry analyzers market in Asia Pacific during the forecast period.
A large number of suppliers of dry chemistry analyzers compete in the market in terms of extension of test parameters, lowering of test cost, and efficacy of analyzers. Key players in the global dry chemistry analyzers market include Ortho Clinical Diagnostics, Fujifilm Corporation, ARKRAY, Diatest GmbH, ACON Laboratories, Inc., MedTest, Abbott, F. Hoffmann-La Roche Ltd., and Kontrolab.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.